IMM 0.81% 31.3¢ immutep limited

CHECKPOINT INHIBITORS - What The?, page-13

  1. 25,484 Posts.
    lightbulb Created with Sketch. 1388
    note: immutep targeted combo patents expiring 2036 citing both keytruda and opdivo with efti...
    also note: keytruda patent expires circa 2025/2026...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.